Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CNCE

Concert Pharmaceuticals (CNCE)

Concert Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CNCE
DateTimeSourceHeadlineSymbolCompany
17/03/202300:02Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202321:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202321:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202321:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/03/202321:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:58Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:53Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:42Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:33Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202303:23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202301:47Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202301:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CNCEConcert Pharmaceuticals Inc
07/03/202301:01Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
25/02/202308:06Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
25/02/202308:03Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
17/02/202300:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
17/02/202300:49Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
17/02/202300:48Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202323:00Business WireConcert Pharmaceuticals Maintains Deuruxolitinib Breakthrough Therapy Designation from FDA for the Treatment of Alopecia AreataNASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202309:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
15/02/202306:36Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CNCEConcert Pharmaceuticals Inc
14/02/202301:26Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CNCEConcert Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CNCE